Syntec Optics Holdings, Inc. — 2023 Form 10-K
Reporting period: Fiscal year ended December 31, 2023; the filing does not provide a clear standalone fourth-quarter results table. Legacy Syntec is the accounting acquirer in the November 7, 2023 business combination, which was accounted for as a reverse recapitalization. The audited statements cover the operating business for the full year.
Business context
Syntec manufactures optics and photonics components and subsystems, including polymer and glass optics, tooling, coatings, and assemblies. Its markets include defense, medical, consumer/industrial, and, beginning in 2023, communications. Manufacturing is concentrated at its leased Rochester, New York facility.
Financial results
| Metric | 2023 | 2022 | Change / context |
|---|---|---|---|
| Revenue | $29.44 million | $27.84 million | Up 5.8% |
| Gross profit / margin | $7.92 million / 26.9% | $6.13 million / 22.0% | Margin improved about 4.9 percentage points |
| Operating income (loss) | $1.54 million | ($0.53 million) | Returned to operating profitability |
| Net income (loss) | $1.98 million | ($0.43 million) | 2023 includes a $0.72 million income-tax benefit |
| Adjusted EBITDA | $5.33 million | $4.50 million | Non-GAAP measure; excludes specified non-recurring items |
| Cash from operations | $2.79 million | $1.93 million | Higher than prior year |
| Cash used in investing | ($1.92 million) | ($0.69 million) | Higher capital expenditures |
| Cash from (used in) financing | $0.76 million | ($3.02 million) | Includes business-combination proceeds and debt activity |
Revenue growth was mainly attributable to approximately $1.9 million more non-recurring engineering work related to space communications. Product revenue declined approximately $0.3 million. By end market, communications contributed $5.32 million in 2023; consumer revenue was $7.03 million versus $8.97 million, and medical revenue was $9.64 million versus $11.46 million. Defense revenue was approximately flat at $7.46 million.
Liquidity, debt and capital
- Year-end cash was $2.16 million, compared with $0.53 million a year earlier. Current assets were $15.15 million and current liabilities $11.38 million.
- Reported borrowings totaled approximately $8.9 million, including $6.54 million drawn on a $10 million revolving line. The company reported $6.5 million of variable-rate debt; a 100-basis-point rate increase was estimated to add about $65,000 in annual pretax interest expense.
- The November 2023 refinancing increased the revolver from $8 million to $10 million and reduced the stated spread to 225 basis points over one-month SOFR. It also provided for a term facility of up to $1.775 million and a discretionary equipment financing limit of $5 million. The company reported covenant compliance at year-end.
- Management stated that available cash was expected to cover working capital and capital expenditure needs for at least 12 months from the filing date, while noting that additional financing might be needed for strategic acquisitions or adverse developments.
- No cash dividends are planned for the foreseeable future. The business combination added approximately $1.69 million net to equity after specified transaction costs and liabilities, according to the filing.
Material changes, outlook and risks
- Gross margin improved as revenue rose and cost of goods sold declined slightly. Net income also benefited from a $719,000 income-tax benefit, primarily related to deferred tax assets; the filing reports a negative 57.2% effective tax rate for 2023.
- The company entered communications in 2023 and is a supplier on a NIST-funded sensing research and development project. Management describes growth plans focused on new markets, automation, product expansion, and potential acquisitions. No formal revenue or earnings guidance is provided in this filing.
- Business-combination earnout terms provide for up to 26 million shares to legacy stockholders if specified share-price thresholds are achieved within five years. A separate management performance award of up to 2 million shares is tied to revenue and adjusted EBITDA thresholds of $75 million and $22.6 million for 2024, and $196 million and $50.6 million for 2025. These are transaction award conditions, not stated operating guidance.
- Three customers accounted for 53% of 2023 revenue, compared with 50% in 2022; those customers also represented 67% of year-end receivables. The company depends on one manufacturing facility and identifies customer concentration, supply-chain disruption, inflation, interest rates, and access to capital as risks.
- Management concluded disclosure controls were not effective at December 31, 2023 because of material weaknesses, including insufficient control documentation and segregation of duties, untimely reconciliations, cost cut-off and related-party controls, complex earnout valuation controls, and IT access, change-management, and cybersecurity controls. Remediation is underway. The auditor gave an unqualified opinion on the financial statements but did not opine on internal-control effectiveness.
- Other notable items include $300,000 of grant revenue recognized after grant requirements were fulfilled, insurance receipts related to the 2022 power outage, and a December 2023 purchase of machinery and intellectual property assets from Molex for approximately $560,000. Management said it was not party to legal proceedings likely to have a material adverse effect.
Important facts for investors to verify
- Whether customer concentration, receivables collection, and the new communications revenue stream remain sustainable, particularly as 2023 revenue growth was driven largely by non-recurring engineering services.
- Progress in remediating the disclosed material weaknesses, especially accounting close, cost cut-off, related-party disclosures, earnout valuation, and IT controls.
- Liquidity and covenant headroom under the variable-rate credit facilities, and whether planned investment or acquisitions require additional financing.
- The potential dilution and accounting implications of the 26 million contingent earnout shares, management awards, and 14.1 million warrants exercisable at $11.50 per share.
- The 2022 auditor report’s note that prior disclosures were revised, including a covenant violation subsequently waived by the lender; investors should review the related financial-statement notes and any effects on comparability.